Lanreotide Acetate

Nomen		Lanreotide Acetate
Synonyma		10-(4-aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1-carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl )methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-di thia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;Somatulina;LANREOTIDEACETATE;3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L tyrosyl-D-tryptophyl-L-lysyl- L-valyl-L-cysteinyl-L-threoninamidecycChemic albooklic(2 →7)-disulfideacetate; Angiopeptinacetate; -2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol- 3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;LanreotideAcetateUSP/EP /BP;10-(4-aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)a...
M
Formulae hypotheticae		C54H69N11O10S2
M. Pondus		1096.326
CAS Subcriptio Number		127984-74-1

Pertractatio et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum